Medical Technology and Devices completed the acquisition of the pen needle and BGM businesses from Ypsomed.

Medical Technology and Devices, an international group active in the design and production of medical devices for home and professional assistance, completed the acquisition of the pen needle and BGM businesses from Ypsomed, a firm engaged in the development, manufacture and sale of its own high-quality medical technology products. Financial terms were not disclosed. "The completion of this acquisition marks a transformative moment for MTD Group. By integrating Ypsomed's Pen Needles and Blood Glucose Monitoring businesses, we solidify our position as a global leader in diabetes care and establish ourselves as the second-largest producer of pen needles worldwide. This strategic move enhances our ability to deliver innovative, high-quality solutions to our customers and expands our reach into key markets. Our significant investments underscore our commitment to scaling our operations efficiently while maintaining the highest standards of quality. We are excited about the opportunities this acquisition presents and remain dedicated to advancing the future of diabetes care," Charles Bouaziz, MTD Group CEO.